KUALA LUMPUR, July 22 — Antah Pharma Sdn Bhd yesterday signed a deal with Pharmaniaga LifeScience Sdn Bhd to distribute Sinovac’s Covid-19 vaccine for sale to the general public.
The supply and distribution agreement enables Antah Pharma, a subsidiary of Antah HealthCare Group, to supply and distribute the Sinovac vaccine to any individuals through its sales channels, such as employers, general physician clinics, hospitals and pharmacies.
“We are extremely delighted to be selected as a partner to work with Pharmaniaga in providing vaccines to Malaysians,” Antah HealthCare Group CEO Mohamed Alauddin, the Group CEO of Antah HealthCare Group said in a statement today.
“I believe the government has been working hard in accelerating the vaccine process but with a private partnership like this, I believe we can achieve herd immunity faster than expected.
“We are thrilled to be part of this journey and we hope through us, the vaccine will be easily accessible to everyone since anyone can purchase it. Through our distribution network, the Sinovac vaccine will be available to Malaysians, complementing the government’s effort in accelerating the vaccination process.”
Antah Pharma also mentioned that it would offer on-site vaccination services for its corporate clients, or customers may choose to get their vaccine through its panel doctors and clinics nationwide. Interested parties may make bookings by emailing [email protected]
Yesterday, Deputy Prime Minister Ismail Sabri Yaakob announced Pharmaniaga’s intention to sell 14 million Sinovac doses to private companies as well as state governments in Malaysia.
The delivery of the double-shot Sinovac vaccines to the private market is expected to happen between this month and September.
The Selangor state government has already procured 2.5 million doses of Sinovac’s vaccine from Pharmaniaga Bhd to inoculate 1.25 million of its residents under the state’s Selvax vaccination drive.
The state government is now expected to receive 250,000 doses of Sinovac vaccine to vaccinate 125,000 industry workers in Selangor under the Selvax Industry programme, after receiving about 40,000 doses for the initial phase of Selvax.
As Pharmaniaga mentioned earlier, after completing its Sinovac vaccine delivery contract with the government, the local pharmaceutical company will be distributing the vaccines to the private market.
Initially, Pharmaniaga was contracted by the federal government to supply 12 million doses of the Sinovac vaccine through its local manufacturing fill-and-finish process and finished product from Beijing, China.
Pharmaniaga delivered the last batch of Sinovac doses to the federal government yesterday, four and a half months earlier than its original schedule for Putrajaya’s order.
Last week, the federal government announced that it will procure an additional three million Sinovac doses from Pharmaniaga, bringing the total order of Sinovac doses by the Malaysian government to 15 million.